2011
DOI: 10.1161/atvbaha.110.222240
|View full text |Cite
|
Sign up to set email alerts
|

Double Attack on Tumors by Targeting With Guidance Molecules

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2011
2011
2014
2014

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(7 citation statements)
references
References 13 publications
0
7
0
Order By: Relevance
“…For example, β-blockers are being considered to be a novel adjuvant to existing therapeutic strategies in clinical oncology (73). Finally, as important modulators in the nervous system and cancer, neurotrophic factors, neuropilins, axonal guidance molecules, neurotransmitters and their receptors are being considered to exploit new drugs to be used to treat metastasis (78,82,111,165,234,246250). …”
Section: Clinical and Biological Implications For The Role Of Nervousmentioning
confidence: 99%
“…For example, β-blockers are being considered to be a novel adjuvant to existing therapeutic strategies in clinical oncology (73). Finally, as important modulators in the nervous system and cancer, neurotrophic factors, neuropilins, axonal guidance molecules, neurotransmitters and their receptors are being considered to exploit new drugs to be used to treat metastasis (78,82,111,165,234,246250). …”
Section: Clinical and Biological Implications For The Role Of Nervousmentioning
confidence: 99%
“…29 Since VEGF-targeted therapies have been shown to have limited efficacy, the concept of targeting stromal cells in general has been brought to the forefront. 30 Guidance molecules including semaphorins, ephrins, netrins, and slit, well known to influence neuronal guidance, also have a role in vascular remodeling. 31 More specifically, semaphorins interact with Neuropilin-1 (NRP1) receptors to inhibit migration of endothelial and tumor cells alike.…”
Section: The Tumor Vasculaturementioning
confidence: 99%
“…50 Because NRP1 and 2 are expressed on both tumor and endothelial cells, it has been demonstrated that Sema3A can be used to target cancer with a dual approach. 30 The interacting region of NRP with VEGF is distinct from that of semaphorins, and it is mediated via its b1b2 extracellular domains. 51,52 NRP1 has a short cytoplasmic tail with a single PDZbinding domain, but it contains no inherent enzymatic activity, and its ability to signal on its own is not clear at this point.…”
Section: Monographsmentioning
confidence: 99%
“…Recently, analyses of the angiogenic processes led to the identification of new proteins involved in the migration of ECs (summarized in table 1). These new antiangiogenic strategies could have a special role when combined with VEGF inhibition, maybe to overcome antiangiogenic resistance [41]. In which tumor stage these new antiangiogenic strategies should be incorporated is not yet clear.…”
Section: Discussionmentioning
confidence: 99%
“…2 Guidance molecules inhibit tumor progression by several ways. Adapted from Weick et al [41]. Thereby, semaphorins induce direct apoptotic effects on tumor cells.…”
Section: Robo Receptors Stabilize the Angiogenic Network Counteractinmentioning
confidence: 99%